课题基金 / 基金详情

FLUDROCORTISONE ON BLOOD PRESSURE IN EUVOLEMIC HEMODIALYSIS PATIENTS

FLUDROCORTISONE ON BLOOD PRESSURE IN EUVOLEMIC HEMODIALYSIS PATIENTS
氟氢可的松对等容量血液透析患者血压的影响
批准号:
6278273
负责人:
THOMAS H HOSTETTER
金额:
$3.69万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1997
资助国家:
美国
项目状态:
已结题
起止时间:
1997-12-01 至 1998-11-30

项目摘要

项目成果

THOMAS H HOSTETTER的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Protocol 533 addresses the mechanism involved in generating hypertension by mineralocorticoids. The most commonly accepted mechanism is that mineralocorticoids cause hypertension through salt retention and subsequent volume expansion. This study addresses another possibility, namely, direct vascular effects of aldosterone that are independent of volume retention. This is achieved by keeping dialysis patients at the same weight while receiving fludrocortisone.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
PATHOPHYSIOLOGY & RENIN ANGIOTENSIN ALDOSTERONE SYSEM & CHRONIC REJECTION
  • 批准号:
    6264835
  • 项目类别:
  • 资助金额:
    $4.48万
  • 财政年份:
    1998
  • 负责人:
    THOMAS H HOSTETTER
  • 依托单位:
EEFECT OF PROTEIN INTAKE ON NUTRITIONAL STATUS AND RENAL FUNCTION
  • 批准号:
    6248153
  • 项目类别:
  • 资助金额:
    $3.23万
  • 财政年份:
    1997
  • 负责人:
    THOMAS H HOSTETTER
  • 依托单位:
RENAL HEMODYNAMICS AFTER PROTEIN MEAL
  • 批准号:
    4702639
  • 项目类别:
  • 资助金额:
    $0.0万
  • 财政年份:
    --
  • 负责人:
    THOMAS H HOSTETTER
  • 依托单位:
PROTEIN INTAKE ON NUTRITIONAL STATUS & RENAL FUNCTION IN CHRONIC RENAL REJECTION
  • 批准号:
    5220349
  • 项目类别:
  • 资助金额:
    $0.0万
  • 财政年份:
    --
  • 负责人:
    THOMAS H HOSTETTER
  • 依托单位:
    --
海外基金